News from the healthcare data industry
By Enno Behrendt and Liisa M. Eisenlohr, Guidehouse While randomized clinical trials (RCTs) remain the gold standard for evaluating the safety and efficacy of new therapeutic agents, innovators and regulators alike envision a future in which the full scope of real-world data (RWD) can be used to generate real-world evidence…
September 26, 2022 06:59 AM Eastern Daylight Time DENVER–(BUSINESS WIRE)–Palantir Technologies Inc. (NYSE: PLTR) announced today that the Department of Homeland Security renewed its contract to support Homeland Security Investigations (HSI) with Investigative Case Management (ICM) software. The contract is worth $95.9M over a five-year period. Since 2011, Palantir has…
CHICAGO and WARSAW, Poland, Sept. 26, 2022 /PRNewswire/ — Prosoma Digital Therapeutics, innovators in reinventing healthcare for oncology patients, has partnered with EVERSANA®, a pioneer of next-generation commercial services to the global life sciences industry, to support the expected launch and commercialisation for Prosoma’s digital therapy to support the mental health of cancer patients. The digital…
Partnership broadens precision medicine access at the point of care with seamless ordering and receipt of Caris molecular profiling results directly in patient records via the OncoEMR® platform IRVING, Texas, Sept. 23, 2022 /PRNewswire/ — Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize…
Real World Evidence (RWE) plays an increasingly important role across the lifecycle of a drug, and supports innovation in clinical operations, regulatory, medical affairs, market access and safety. As regulatory bodies around the globe issue new guidance on the use of RWE, as HCP and patient expectations evolve, and as…
By Patricia Allen Lausanne-headquartered Hedera Dx is pioneering the adoption of liquid biopsy in cancer treatments. The biotech startup has just raised €14 million to push forward its mission of bringing better access to cutting-edge treatments to patients around the world. Cancer. One of the world’s most prevalent and devastating illnesses, it’s…
Underdosing of non-vitamin K oral anticoagulants (NOACs) is common in patients with atrial fibrillation (AF), and may be associated with an increased risk of stroke without reducing the risk of major bleeding. At the Advances in Medicine 2022 conference, Professor Martin Grond of Kreisklinikum Siegen in Siegen, Germany, discussed optimal…
nference’s new privacy-preserving nSights platform accelerates development of therapeutics and diagnostics for life sciences companies September 21, 2022 08:45 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–nference, a science-first software company transforming healthcare by making biomedical data computable, today announced the launch of its AI-driven nSights platform, which will allow biopharma, medical…
Studies Will Examine Social Determinants of Health, Impact of Policy on Access, and Pandemic-Driven Disruptions to Healthcare Delivery September 21, 2022 08:00 AM Eastern Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–Today, Komodo Health announced a new partnership with the University of Maryland School of Pharmacy (UMSOP), providing its researchers and clinicians with…
September 21, 2022 07:00 AM Eastern Daylight Time CAMBRIDGE, Mass. & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Foundation Medicine, Inc., a pioneer in molecular profiling for cancer, and Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced…